NCT00096707 - Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Lung CancerBreast CancerPancreatic CancerHead and Neck CancerGastric Cancer

Interventions

DRUG

2-deoxy-D-glucose (2DG)

Trial Locations (3)

University of Miami Sylvester Comprehensive Cancer Center, Miami

Indiana University Cancer Center, Indianapolis

Institute for Drug Development Cancer Therapy & Research Center, San Antonio